key: cord-0324248-1bmirnfq
authors: Li, Jiao; Xue, Ling; Wang, Jiachao; Meng, Aihong; Qiao, Jiajun; Li, Miao; Wang, Xiuli; Meng, Lingtong; Ning, Jingyuan; Gao, Xue; Li, Wenjian; Ma, Cuiqing; Wei, Lin
title: Activation of the chemokine receptor CCR1 and preferential recruitment of Gαi suppress RSV replication: implications for developing novel RSV treatment strategies
date: 2022-03-19
journal: bioRxiv
DOI: 10.1101/2022.03.18.484968
sha: 80c149f131050bcf5cd79b3b7a9f06fbe428da88
doc_id: 324248
cord_uid: 1bmirnfq

Respiratory syncytial virus (RSV) is a major pathogen that can cause acute respiratory infectious diseases of the upper and lower respiratory tract, especially in children, elderly individuals and immunocompromised people. Generally, following viral infection, respiratory epithelial cells secrete cytokines and chemokines to recruit immune cells and initiate innate and/or adaptive immune responses. However, whether chemokines affect viral replication in non-immune cells is rarely clear. In this study, we detect that chemokine CCL5 was highly expressed, while expression of its receptor, CCR1, was downregulated in respiratory epithelial cells after RSV infection. When we overexpressed CCR1 on respiratory epithelial cells in vivo/in vitro, viral load was significantly suppressed, which can be restored by the neutralizing antibody for CCR1. Interestingly, the antiviral effect of CCR1 was not related to type I interferon (IFN-I), apoptosis induction or viral adhesion or entry inhibition; in contrast, it was related to the preferential recruitment and activation of adaptor Gαi, which promoted inositol 1,4,5-triphosphate receptor type 3 (ITPR3) expression, leading to inhibited STAT3 phosphorylation, explicitly, phosphorylated (p)-STAT3 was verified to be among the important factors regulating the activity of HSP90, which has been previously reported to be a chaperone of RSV RNA polymerase. In summary, we are the first to reveal that CCR1 on the surface of non-immune cells regulates RSV replication through a previously unknown mechanism that does not involve IFN-I induction.

significantly and was negatively correlated with the replication of intracellular 88 virus 89 In the study of RSV pathogenic mechanisms, Hep2 laryngeal cancer epithelial cells, 127 CCL5 exerts its biological effect through its receptors, which include CCR1, CCR3 128 and CCR5. Therefore, we measured the expression levels of these three receptors in 129 cells infected with RSV. We found that the expression level of CCR1 was decreased, 130 7 that of CCR5 was increased, and that of CCR3 expression did not significantly change 131 ( Fig. 2A) . Then, A549 cells were first transfected with CCR1, CCR3 or CCR5 The CCR1 expression level was negatively correlated with RSV replication 146 After 24 hours of infection with RSV, viral proliferation was significantly reduced in 147 A549 cells overexpressing CCR1 (1000 ng of pcDNA3.1-CCR1) compared with that 148 in the control group cells (Fig. 3A and B) , and with the increase in CCR1 149 overexpression, the intracellular viral load gradually decreased ( Fig. 3C and D) , 150 suggesting that CCR1 expression was negatively correlated with RSV replication.

Furthermore, A549 cells were pretreated with different concentrations of anti-CCR1 152 8 neutralizing antibodies and then infected with RSV, and the analysis showed that the 153 viral load gradually recovered in a dose-dependent manner with the increase in 154 neutralizing antibody concentration ( Fig. 3E and F) , indicating that RSV replication 155 was resumed after the binding of CCR1 and its ligand was blocked. Then, after RSV 156 infection of CCR1-knockdown A549 cells for 24 hours, the intracellular viral protein 157 level was increased significantly compared with that in the control cells (Fig. 3G showed that the viral load in cells overexpressing CCR1 was not significantly 186 different than that of the control group cells, suggesting that CCR1 overexpression did 187 not affect viral adhesion or entry into cells (Fig. 4E) . Simultaneously, the expression 188 of CX3CR1, the main receptor of RSV, was detected in CCR1-overexpressing A549 189 cells by Western blotting and confocal microscopy, and the results showed that the 190 CX3CR1 expression level did not significantly change compared with that in the 191 control cells (Fig. 4F and G) . Thus, the decrease in intracellular viral load caused by 192 CCR1 overexpression was not due to an effect on the level of the main RSV receptor.

These results showed that CCR1 overexpression had almost no influence on cell 194 apoptosis; the expression of IFN-I or CX3CR1; or RSV adhesion or entry into cells. 198 It has been reported that the RSV RNA polymerase complex consists of viral 199 nucleoprotein (N), large polymerase protein (L) and its cofactor, phosphate protein (P).

The M2-1 protein (which is a polymerase cofactor) is also required for transcriptional To confirm that CCR1 activation by its ligand CCL5 affects RSV intracellular 231 replication, CCR1-overexpressing cells were treated with CCL5, and the results 232 showed that the CDC2 protein level decreased gradually with increasing CCL5 233 protein concentration (Fig. 5F ), suggesting that CCR1 activation by its ligand CCL5 234 downregulates HSP90 activity. In contrast, the level of intracellular viral protein or 235 GFP in the knockdown cells was significantly lower than that in the control cells ( Fig.   236 5G-I). Therefore, we speculated that CCR1 binding to its ligand CCL5 can 237 downregulate HSP90 activity, which in turn affects RSV replication.

Activation of CCR1 by CCL5 leads to the preferential recruitment of the adaptor 240 Gαi, which regulates HSP90 activity to affect RSV replication 241 To further study the possible molecular mechanism by which CCR1 inhibits HSP90 242 activity, we needed understand the process through which the chemokine receptor 243 CCR1 is activated. CCR1 belongs to the seven transmembrane G protein-coupled Interestingly, the ERK phosphorylation level was not related to Gαi but was positively 260 correlated with β-arrestin 2 (Fig. 6C ). All these results indicated that activated CCR1 261 preferentially recruits Gαi to inhibit RSV replication by regulating HSP90 activation 262 13 in a mechanism independent of the ERK pathway. Although another adaptor, 263 β-arrestin2, might promote HSP90 activity by activating ERK kinase, β-arrestin 2 was 264 rarely recruited by CCL5-activated CCR1. When an inhibitor of STAT3 (stattic) inhibited STAT3 phosphorylation, the activity of 301 HSP90 was significantly inhibited, but the expression level of ITPR3 was not affected, 302 indicating that STAT3 is a downstream molecule that is negatively regulated by 303 ITPR3 and that HSP90 is the downstream molecule of STAT3 (Fig. 7I) . Thus, we 304 demonstrated that activated CCR1 tends to preferentially recruit Gαi and that Gαi after RSV infection, and we found that overexpression of CCR1 on these cells neither 399 increased IFN-I production nor the apoptosis rate (Fig. 4) . These results did not verification, we found that, among these proteins, HSP90 was the most meaningful to 408 our study. HSP90 is an essential molecular chaperone required for the maintenance, were overexpressed in A549 cells that were then infected with RSV, and the levels of 469 ERK phosphorylation and CDC2 and viral protein expression were found to be 470 significantly higher in the cells overexpressing both CCR1 and β-arrestin2 than the 471 cells overexpressing only CCR1 (Fig. 6C ). When we inhibited ERK phosphorylation 472 with inhibitors, the CDC2 level gradually decreased with increasing inhibitor 473 concentration, and viral replication gradually decreased (Supplementary Fig. C) . 474 Therefore, we speculated that β-arrestin is recruited and subsequently activates 475 ERK1/2, which upregulates HSP90 activity by influencing the expression or function 476 of a cochaperone, thereby regulating the ability of the cochaperone to facilitate viral 477 replication. However, we found that CCL5-activated CCR1 preferentially recruited 478 Gαi, which rarely affects the ERK kinase pathway (Fig. 6C and D) and that it 

The mice were assigned to 6 groups (n=6 per group). We infected 2 groups of 

Total RNA was isolated with RNAiso Plus reagent (9101; TaKaRa, Japan).

First-strand cDNA was generated with a PrimeScript RT reagent kit (047A; TaKaRa, 563 Japan). Real-time PCR was performed with an ABI Prism 7500 sequence detection Gαi recruited by activated CCR1 upregulates ITPR3, which inhibits STAT3 phosphorylation, thereby affecting HSP90 activity and viral replication. After CCR1-overexpressing A549 cells were treated with or without CCL5, mass spectrometry was performed to analyze the differentially expressed proteins between the two groups (A), and GO enrichment with differentially expressed genes (B) and the interactions of proteins encoded by differentially expressed genes (C) were analyzed. (D) The effect of knocking down ITPR3 expression was verified by qRT-PCR. (E) After ITPR3 expression was knocked down, CCR1-overexpressing A549 cells were stimulated with CCL5 or RSV, and the protein expression levels of CDC2 and RSV-M2 were detected by Western blotting. (F) Following RSV infection, the expression of ITPR3, p-STAT3, CDC2 and viral proteins in CCR1-overexpressing cells was determined by Western blotting. (G, H) After ITPR3 expression was knocked down, CCR1-overexpressing A549 cells were stimulated with RSV or CCL5, and the protein expression level of p-STAT3 was detected by Western blotting. (I) After ITPR3 expression was knocked down, A549 cells overexpressing CCR1 were treated with a STAT3 inhibitor (stattic) and then stimulated with RSV for 24 hours. The protein expression levels of CDC2, p-STAT3 and RSV-M2 were detected by Western blotting. (J) After A549 cells overexpressing CCR1 and/or Gαi were infected with RSV, the protein expression of ITPR3 and p-STAT3 was detected by Western blotting. (Unpaired t test, *P<0.05, **P<0.01, ***P<0.005, and ****P<0.001)

Impact of respiratory syncytial virus in the United States

Epidemiology of viral respiratory infections

Population-based surveillance for hospitalizations 701 associated with respiratory syncytial virus, influenza virus, and parainfluenza 702 viruses among young children

Control of 704 nosocomial respiratory syncytial viral infections

Global burden of acute lower respiratory infections due to 707 respiratory syncytial virus in young children: a systematic review and 708 meta-analysis

Global and regional mortality from 235 causes of death for 710 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden 711 of Disease Study

Chemokines in respiratory viral infections: focus on their diagnostic and 715 therapeutic potential

Modulation of the host immune response by 717 34 respiratory syncytial virus proteins

The Frizzled family of unconventional

G-protein-coupled receptors

Constitutive 721 immune mechanisms: mediators of host defence and immune regulation

Respiratory syncytial virus induces selective production of the 724 chemokine RANTES by upper airway epithelial cells

Expression of respiratory syncytial virus-induced chemokine 727 gene networks in lower airway epithelial cells revealed by cDNA microarrays

Functional diversity of chemokines 730 and chemokine receptors in response to viral infection of the central nervous 731 system

Chemokine regulation of 733 inflammation during acute viral infection

Differential expression of chemokine receptors and 736 chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

CCR1 deficiency increases susceptibility to fatal

Long Noncoding RNA NRAV Promotes Respiratory Syncytial 742

Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To 743

Regulate Vesicle Transportation

Interactome analysis of the human respiratory syncytial 745 virus RNA polymerase complex identifies protein chaperones as important 746 cofactors that promote L-protein stability and RNA synthesis

Conformational 749 dynamics of the molecular chaperone Hsp90

The 'active life' of Hsp90 complexes

Evolutionary constraints 754 on chaperone-mediated folding provide an antiviral approach refractory to 755 development of drug resistance

Antiviral activity 757 and RNA polymerase degradation following Hsp90 inhibition in a range of 758 negative strand viruses

Inhibition of heat-shock protein 90 reduces Ebola virus 760 replication

Hsp90 inhibitors reduce influenza virus replication in cell 762 culture

Broad action of Hsp90 as a host 764 chaperone required for viral replication

Anti-inflammatory drug 767 development: Broad or specific chemokine receptor antagonists

Crystal structure of opsin in its G-protein-interacting 770 conformation

High-resolution distance mapping in rhodopsin reveals the pattern of helix 773 movement due to activation

A) CCL5 expression in the BALF of RSV-infected mice was detected by qRT-PCR. (B) CCR1 expression in the respiratory epithelial cells of RSV-infected mice was analyzed by immunohistochemistry. (C) RFP expression in the lungs of AAV-or AAV-CCR1-transfected mice was detected by whole-lung imaging. (D) CCR1 expression in the lungs of AAV-or AAV-CCR1-transfected mice was detected by immunohistochemistry. (E) The mRNA expression levels of the RSV N and M genes in lung tissue of AAVor AAV-CCR1-transfected mice were detected by qRT-PCR. (F) The RSV load was detected in the lungs of AAV-or AAV-CCR1-transfected mice by whole-lung imaging. (G) Lung inflammation was analyzed by H&E staining

Schematic diagram showing activated CCR1 downregulating HSP90 activity through the

The chemokine CCL5 binds with CCR1 to downregulate HSP90 activity through the Gαi/ITPR3/p-STAT3 pathway, affecting the function of RSV RNA polymerase and inhibiting viral replication